Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I C van Gelder

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 9, 2006
[Rhythm control as treatment for patients with medication-resistant atrial fibrillation: maze surgery and percutaneous pulmonary vein isolation by catheter ablation]I C van Gelder
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Differences in guidelines for the diagnostic evaluation and treatment of atrial fibrillationI C van Gelder
European Heart Journal|April 1, 1995
Therapy of recent onset atrial fibrillation and flutter in haemodynamically compromised patients: chemical conversion or control of the ventricular rate?K I Lie, I C van Gelder
Pacing and Clinical Electrophysiology : PACE|November 14, 1997
Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythmI C Van Gelder, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 14, 2011
Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?M D Smit, I C Van Gelder
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 31, 2008
Atrial pacing for rhythm control of atrial fibrillationI C van Gelder, A C P Wiesfeld
Drugs|April 8, 1998
Current treatment recommendations in antiarrhythmic therapyI C Van Gelder, J Brügemann, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 12, 2020
Paradigm shifts in pathophysiology and management of atrial fibrillation-a tale of the RACE trials in the NetherlandsH J G M Crijns, I C Van Gelder
Journal of the American College of Cardiology|November 3, 2001
Atrial fibrillation and sinus node dysfunctionM P van den Berg, I C van Gelder
Drugs & Aging|August 1, 1997
Pharmacological management of arrhythmias in the elderlyI C Van Gelder, J Brügemann, H J Crijns
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Nederlands Tijdschrift Voor Geneeskunde|November 9, 2006
[Rhythm control as treatment for patients with medication-resistant atrial fibrillation: maze surgery and percutaneous pulmonary vein isolation by catheter ablation]I C van Gelder
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Differences in guidelines for the diagnostic evaluation and treatment of atrial fibrillationI C van Gelder
European Heart Journal|April 1, 1995
Therapy of recent onset atrial fibrillation and flutter in haemodynamically compromised patients: chemical conversion or control of the ventricular rate?K I Lie, I C van Gelder
Pacing and Clinical Electrophysiology : PACE|November 14, 1997
Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythmI C Van Gelder, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 14, 2011
Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?M D Smit, I C Van Gelder
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 31, 2008
Atrial pacing for rhythm control of atrial fibrillationI C van Gelder, A C P Wiesfeld
Drugs|April 8, 1998
Current treatment recommendations in antiarrhythmic therapyI C Van Gelder, J Brügemann, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 12, 2020
Paradigm shifts in pathophysiology and management of atrial fibrillation-a tale of the RACE trials in the NetherlandsH J G M Crijns, I C Van Gelder
Journal of the American College of Cardiology|November 3, 2001
Atrial fibrillation and sinus node dysfunctionM P van den Berg, I C van Gelder
Drugs & Aging|August 1, 1997
Pharmacological management of arrhythmias in the elderlyI C Van Gelder, J Brügemann, H J Crijns
Pageof 11